AMS: American Shared Hospital Services Inc Price-to-Revenue Coefficient

Corporate company logo of ASHS (AMS)

The fundamental P/S for American Shared Hospital (AMS) reflects market fluctuations in asset valuation, with the parameter reaching 0.20. Current momentum is driven by the implementation of ESG standards in medical equipment leasing. Long-term leasing agreements for Gamma Knife systems are fueling growth, although expansion is limited by a lack of proprietary development, as American Shared Hospital (AMS) merely integrates third-party solutions for oncology centers.

AMS American Shared Hospital: P/S Multiple in the range 07/04/2022 - 11/13/2026

American Shared Hospital Services, Inc. (AMS) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company analysis:AMS, ashs.com
Manufactured products of ASHS

Investors utilize this screening to determine the market overvaluation of the business relative to its ability to generate revenue. The metric is calculated by dividing the total market capitalization of American Shared Hospital (AMS) by annual revenue, measuring the cost of each dollar of sales. For American Shared Hospital, this reflects the monetization efficiency of radiosurgical equipment leasing and the accessibility of Gamma Knives. The price-to-sales trend allows for an objective comparison of the company's valuation against US industry standards.

Competing companies

HCA (hcahealthcare.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple THC (Tenet Healthcare Corporation)|Price-to-Revenue Coefficient Fresenius Medical Care AG (FMS)|Solventum Inc. - P/S Multiple|Encompass (EHC) - Market Cap to Revenue|UHS: P/S Multiple|davita.com (DVA) - P/S Multiple|Price-to-Revenue Ratio RadNet|Market Cap to Revenue Ratio OPCH (Option Care)|Market Cap to Revenue SGRY (Surgery Partners Corp)|PINC (Premier Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio National Vision Holdings EYE|Price-to-Revenue Coefficient progyny.com (PGNY)|Ardent Health Partners - P/S Multiple|Market Capitalization-to-Revenue Ratio SEM (Select Medical Corporation)|ASTH: P/S Multiple|MEDNAX (MD) - P/S Multiple|Price-to-Revenue Ratio US Physical Therapy|PNTG: Market Capitalization-to-Revenue Ratio|P/S Multiple ORGO|NUTX - Price to Sales|P/S Multiple AUNA (Auna Health)|SBC: Market Cap to Revenue Ratio|EOLS: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio CYH (chs.net)|SKIN: P/S Multiple|MediWound - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Biote Corp|Price to Sales The Joint JYNT|Price-to-Revenue Ratio DocGo Inc. (DCGO)|Price-to-Revenue Coefficient p3hp.org|Price-to-Revenue Ratio Gain Therapeutics GANX|EUDA (EUDA Health Holdings) - Price-to-Sales Ratio|Basel Medical Group Limited - P/S Multiple|Price-to-Revenue Coefficient CollPlant Biotechnologies CLGN|CUPR (Cuprina Holdings (Cayman) Ltd) - Market Cap to Revenue|CCM: Market Cap to Sales Volume|MRM (MEDIROM Healthcare Group) - P/S Multiple|P/S Multiple Avalon GloboCare Corporation|Price-to-Revenue Ratio DIH Holding US Inc. (DHAI)|Price-to-Revenue Ratio XAGE (Carmell Corp)|P/S Multiple NIVF (NewGenIvf Group Limited)|P/S Multiple ATI Physical Therapy Inc. ATIP|CMAX - Price-to-Revenue Ratio|Kindly MD Inc (KDLY) - Market Cap to Revenue|LogistiCare (MODV) - Price-to-Revenue Ratio|NVOS - Price-to-Revenue Coefficient|Market Cap to Revenue SSY|BACK (imacholdings.comm) - Market Cap to Sales Volume